FRAX™ and the assessment of fracture probability in men and women from the UK

[1]  D. Stoicănescu,et al.  A family history of fracture and fracture risk , 2009 .

[2]  C. Cooper,et al.  The cost-effectiveness of alendronate in the management of osteoporosis. , 2008, Bone.

[3]  A. Silman,et al.  Predictive value of BMD for hip and other fractures (Journal of Bone and Mineral Research (2005) 20, (1185-1194)) , 2007 .

[4]  Jacques P. Brown,et al.  The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women , 2007, Osteoporosis International.

[5]  J. Reginster,et al.  Vertebral Fracture Risk Reduction With Strontium Ranelate in Women With Postmenopausal Osteoporosis Is Independent of Baseline Risk Factors , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  A. Silman,et al.  Predictive Value of BMD for Hip and Other Fractures , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  H. Kroger,et al.  Body mass index as a predictor of fracture risk: A meta-analysis , 2005, Osteoporosis International.

[8]  P. Vestergaard,et al.  Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk , 2005, Diabetologia.

[9]  C. Cooper,et al.  A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids. , 2005, QJM : monthly journal of the Association of Physicians.

[10]  J. Kanis,et al.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report , 1994, Osteoporosis International.

[11]  Olof Johnell,et al.  Alcohol intake as a risk factor for fracture , 2005, Osteoporosis International.

[12]  Eugene McCloskey,et al.  A meta-analysis of milk intake and fracture risk: low utility for case finding , 2005, Osteoporosis International.

[13]  O. Johnell,et al.  Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture , 2005, Osteoporosis International.

[14]  O. Johnell,et al.  The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approach , 2005, Osteoporosis International.

[15]  H. Kroger,et al.  Smoking and fracture risk: a meta-analysis , 2005, Osteoporosis International.

[16]  O. Johnell,et al.  The burden of hospitalised fractures in Sweden , 2005, Osteoporosis International.

[17]  O Johnell,et al.  A family history of fracture and fracture risk: a meta-analysis. , 2004, Bone.

[18]  Tom Chan,et al.  Problems with primary care data quality: osteoporosis as an exemplar. , 2004, Informatics in primary care.

[19]  O Johnell,et al.  A meta-analysis of previous fracture and subsequent fracture risk. , 2004, Bone.

[20]  Olof Johnell,et al.  A Meta‐Analysis of Prior Corticosteroid Use and Fracture Risk , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  E. Barrett-Connor,et al.  An approach to identifying osteopenic women at increased short-term risk of fracture. , 2004, Archives of internal medicine.

[22]  J. Kanis,et al.  Clodronate Reduces Vertebral Fracture Risk in Women With Postmenopausal or Secondary Osteoporosis: Results of a Double‐Blind, Placebo‐Controlled 3‐Year Study , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  O. Johnell,et al.  Associations Between Baseline Risk Factors and Vertebral Fracture Risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) Study , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  A. Oberg,et al.  Long-term fracture risk following renal transplantation: a population-based study , 2004, Osteoporosis International.

[25]  C. Cooper,et al.  Inflammatory bowel disease and the risk of fracture. , 2003, Gastroenterology.

[26]  H. Genant,et al.  Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. , 2003, Bone.

[27]  C. McGraw.  Risk of stroke , 2003 .

[28]  P. Vestergaard,et al.  Hyperthyroidism, bone mineral, and fracture risk--a meta-analysis. , 2003, Thyroid : official journal of the American Thyroid Association.

[29]  H. Tunstall-Pedoe,et al.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.

[30]  A. Oberg,et al.  Fracture risk following bilateral orchiectomy. , 2003, The Journal of urology.

[31]  A. Oberg,et al.  Fracture Risk After Bilateral Oophorectomy in Elderly Women , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  Catherine Eng,et al.  Risk of Hip Fracture in Disabled Community‐Living Older Adults , 2003, Journal of the American Geriatrics Society.

[33]  R. Marcus,et al.  The Skeletal Response to Teriparatide Is Largely Independent of Age, Initial Bone Mineral Density, and Prevalent Vertebral Fractures in Postmenopausal Women With Osteoporosis , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  P. Delmas,et al.  Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women: the OFELY study. , 2003, Bone.

[35]  C. Pieper,et al.  Can Historical and Functional Risk Factors be Used to Predict Fractures in Community-Dwelling Older Adults? Development and Validation of a Clinical Tool , 2002, Osteoporosis International.

[36]  C. Cooper,et al.  Utility of medical and drug history in fracture risk prediction among men and women. , 2002, Bone.

[37]  L. Melton,et al.  Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota. , 2002, Gastroenterology.

[38]  J. Chandler,et al.  Prediction of Fracture in Nursing Home Residents , 2002, Journal of the American Geriatrics Society.

[39]  O. Johnell,et al.  International Variations in Hip Fracture Probabilities: Implications for Risk Assessment , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  Peter Vestergaard,et al.  Fracture risk in patients with celiac Disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. , 2002, American journal of epidemiology.

[41]  P. Dargent-Molina,et al.  Use of Clinical Risk Factors in Elderly Women with Low Bone Mineral Density to Identify Women at Higher Risk of Hip Fracture: The EPIDOS Prospective Study , 2002, Osteoporosis International.

[42]  R. Stevens,et al.  UKPDS 60: Risk of Stroke in Type 2 Diabetes Estimated by the UK Prospective Diabetes Study Risk Engine , 2002, Stroke.

[43]  W. Leslie,et al.  Bone mineral density testing in healthy postmenopausal women. The role of clinical risk factor assessment in determining fracture risk. , 2002, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[44]  J. Kanis,et al.  Diagnosis of osteoporosis and assessment of fracture risk , 2002, The Lancet.

[45]  P. Vestergaard,et al.  Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. , 2002, Thyroid : official journal of the American Thyroid Association.

[46]  M. Dennis,et al.  Fractures After Stroke: Frequency, Types, and Associations , 2002, Stroke.

[47]  R. Holman,et al.  Erratum: The UKPDS risk engine: A model for the risk of coronary heart disease in type II diabetes (UKPDS 56) (Clinical Science (2001) 101 (671-679)) , 2002 .

[48]  O. Johnell,et al.  Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies. , 2002, Bone.

[49]  M. Clarke,et al.  Evaluation of a Hip Fracture Risk Score for Assessing Elderly Women: The Melton Osteoporotic Fracture (MOF) Study , 2002, Osteoporosis International.

[50]  J A Kanis,et al.  Treatment of established osteoporosis: a systematic review and cost-utility analysis. , 2002, Health technology assessment.

[51]  R. Holman,et al.  The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). , 2001, Clinical science.

[52]  G. Westfall,et al.  Methodology for identifying patients at high risk for osteoporotic fracture. , 2001, Clinical therapeutics.

[53]  P. Vestergaard,et al.  Fracture risk in patients with muscular dystrophy and spinal muscular atrophy. , 2001, Journal of rehabilitation medicine.

[54]  A. Folsom,et al.  Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. , 2001, Diabetes care.

[55]  D. Bauer,et al.  Risk for Fracture in Women with Low Serum Levels of Thyroid-Stimulating Hormone , 2001, Annals of Internal Medicine.

[56]  P. Simpson,et al.  Statistical methods in cancer research , 2001, Journal of surgical oncology.

[57]  O. Johnell,et al.  Acute and Long-Term Increase in Fracture Risk After Hospitalization for Stroke , 2001, Stroke.

[58]  P Geusens,et al.  Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. , 2001, The New England journal of medicine.

[59]  B. Bengtsson,et al.  The Influence of Growth Hormone Deficiency, Growth Hormone Replacement Therapy, and Other Aspects of Hypopituitarism on Fracture Rate and Bone Mineral Density , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[60]  Jacques P. Brown,et al.  Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial. , 2001, Arthritis and rheumatism.

[61]  R. Goodman,et al.  The effect of risedronate on the risk of hip fracture in elderly women. , 2001, The New England journal of medicine.

[62]  S. Cummings,et al.  Older women with diabetes have an increased risk of fracture: a prospective study. , 2001, The Journal of clinical endocrinology and metabolism.

[63]  O. Johnell,et al.  The Burden of Osteoporotic Fractures: A Method for Setting Intervention Thresholds , 2001, Osteoporosis International.

[64]  O. Johnell,et al.  An Assessment Tool for Predicting Fracture Risk in Postmenopausal Women , 2001, Osteoporosis International.

[65]  C. Cooper,et al.  Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. , 2000, Rheumatology.

[66]  C. Bernstein,et al.  The Incidence of Fracture among Patients with Inflammatory Bowel Disease: A Population-Based Cohort Study , 2000, Annals of Internal Medicine.

[67]  O Johnell,et al.  Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. , 2000, Bone.

[68]  W. O'Fallon,et al.  Fractures following thyroidectomy in women: a population-based cohort study. , 2000, Bone.

[69]  P. Vestergaard,et al.  Fracture risk in patients treated for hyperthyroidism. , 2000, Thyroid : official journal of the American Thyroid Association.

[70]  R. Honkanen,et al.  Risk Factors for Perimenopausal Distal Forearm Fracture , 2000, Osteoporosis International.

[71]  O. Johnell,et al.  Risk of Hip Fracture Derived from Relative Risks: An Analysis Applied to the Population of Sweden , 2000, Osteoporosis International.

[72]  O. Johnell,et al.  Long-Term Risk of Osteoporotic Fracture in Malmö , 2000, Osteoporosis International.

[73]  J. Kanis,et al.  An Update on the Diagnosis and Assessment of Osteoporosis with Densitometry , 2000, Osteoporosis International.

[74]  M. Hooper,et al.  Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis , 2000, Osteoporosis International.

[75]  A. Hofman,et al.  Added value of bone mineral density in hip fracture risk scores. , 1999, Bone.

[76]  E. Shane,et al.  Bone loss and fracture after lung transplantation. , 1999, Transplantation.

[77]  D. Dunlop,et al.  Increased Risk of Fracture in Patients Receiving Solid Organ Transplants , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[78]  T. Spector,et al.  A high incidence of vertebral fracture in women with breast cancer , 1999, British Journal of Cancer.

[79]  A. LaCroix,et al.  Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. , 1998, JAMA.

[80]  P. Vestergaard,et al.  Fracture rates and risk factors for fractures in patients with spinal cord injury , 1998, Spinal Cord.

[81]  Jacques P. Brown,et al.  Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis , 1998 .

[82]  G. Mclauchlan,et al.  Epidemiology of fractures in 15,000 adults: the influence of age and gender. , 1998, The Journal of bone and joint surgery. British volume.

[83]  Jacques P. Brown,et al.  Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. , 1998, The New England journal of medicine.

[84]  O. Johnell,et al.  Lifetime Risk of Hip Fractures is Underestimated , 1998, Osteoporosis International.

[85]  H. Wahner,et al.  Updated Data on Proximal Femur Bone Mineral Levels of US Adults , 1998, Osteoporosis International.

[86]  M. LeBoff,et al.  Modeling fracture risk using bone density, age, and years since menopause. , 1997, American journal of preventive medicine.

[87]  A Hofman,et al.  Bone density and risk of hip fracture in men and women: cross sectional analysis , 1997, BMJ.

[88]  L. Ramsay,et al.  The Sheffield table for primary prevention of coronary heart disease: corrected , 1996, The Lancet.

[89]  O Johnell,et al.  Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. , 1996, BMJ.

[90]  L. Ramsay,et al.  Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table , 1996, The Lancet.

[91]  R. Honkanen,et al.  Risks of perimenopausal fractures‐a prospective population‐based study , 1995, Acta obstetricia et gynecologica Scandinavica.

[92]  N. Ghannam,et al.  Book review: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. , 1994, Annals of Saudi medicine.

[93]  C. Gillberg,et al.  ANOREXIA NERVOSA: PHYSICAL HEALTH AND NEURODEVELOPMENT AT 16 AND 21 YEARS , 1994, Developmental medicine and child neurology.

[94]  T. Spector,et al.  Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. , 1994, Annals of the rheumatic diseases.

[95]  O Johnell,et al.  Fracture risk in patients with parkinsonism: a population-based study in Olmsted County, Minnesota. , 1992, Age and ageing.

[96]  R. Poses,et al.  Does Hypogonadism Contribute to the Occurrence of a Minimal Trauma Hip Fracture in Elderly Men? , 1991, Journal of the American Geriatrics Society.

[97]  N. Rigotti,et al.  The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass. , 1991, JAMA.

[98]  L. Midanik,et al.  Validity of self-reported alcohol use: a literature review and assessment. , 1988, British journal of addiction.

[99]  C. Slemenda,et al.  Age and bone mass as predictors of fracture in a prospective study. , 1988, The Journal of clinical investigation.

[100]  N E Day,et al.  Statistical methods in cancer research. IARC Workshop 25-27 May 1983. , 1987, IARC scientific publications.

[101]  D J Baylink,et al.  Glucocorticoid-induced osteoporosis. , 1983, The New England journal of medicine.